Treating Advanced Hepatocellular Carcinoma with Sorafenib: A 10-Year Single Center Experience

Overview of attention for article published in GE-Portuguese Journal of Gastroenterology, June 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,232 followers.

RT @GastroKarger: Treating Advanced Hepatocellular Carcinoma with Sorafenib: A 10-Year Single Center Experience ✍ José Presa Ramos 📑 https…

RT @GastroKarger: Treating Advanced Hepatocellular Carcinoma with Sorafenib: A 10-Year Single Center Experience ✍ José Presa Ramos 📑 https…

Treating Advanced Hepatocellular Carcinoma with Sorafenib: A 10-Year Single Center Experience ✍ José Presa Ramos 📑 https://t.co/1QWMsgLlss #GEPortJGastroenterol #OpenAccess #HCC #MVI #Sorafenib https://t.co/Pl22R9EQZI

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.